Novartis (United States)

Novartis (United States)

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Novartis (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

46%


Total
Publications

11K


Total Open
Publications

5.2K


Total
Citations

710K


Open Access
Percentage

46%


Total
Publications

11K


Total Open
Publications

5.2K


Total
Citations

710K

Wikipedia

Website

download

Breakdown

18% 21% 6% 55%

Publisher Open

18%

Both

21%

Other Platform Open

6%

Closed

55%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

050100150200250300350400450500550600650Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

40%OA Journal

OA Journal 40%

1.7K

Hybrid 26%

1.1K

No Guarantees 34%

1.5K

Other Platform Open

Domain 72%

2.3K

Institution 27%

841

Other Internet 20%

619

Public 5%

145

Preprint 1%

24

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
2.3K
DOI
Other Internet
577
DANS - Data Archiving and Networked Services
Institution
182
Europe PMC
Domain
150
Figshare
Public
140
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI
Institution
75
DASH - Digital Access to Scholarship at Harvard
Institution
59
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
48
Unknown Repository
Other Internet
45
Universita Degli Studi Di Milano - Archivio Istituzionale della Ricerca
Institution
36
1 / 18

Data updated 18 August 2025

Share

Share

Share